According to a newly published market research report by 24LifeSciences, global Non-small Cell Lung Cancer (NSCLC) therapeutics market was valued at USD 9.37 billion in 2024 and is projected to reach USD 14.71 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025–2031.

Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15815/non-small-cell-lung-cancer-therapeutics-market

According to a newly published market research report by 24LifeSciences, global silent cancer therapeutics market was valued at USD 3.2 billion in 2024 and is projected to reach USD 5.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period 20252031.

Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15933/silent-cancer-therapeutics-market